[go: up one dir, main page]

WO2011093599A3 - Hydrolysat de levure pour soulager les symptômes de la ménopause chez la femme et aliment le contenant - Google Patents

Hydrolysat de levure pour soulager les symptômes de la ménopause chez la femme et aliment le contenant Download PDF

Info

Publication number
WO2011093599A3
WO2011093599A3 PCT/KR2010/009631 KR2010009631W WO2011093599A3 WO 2011093599 A3 WO2011093599 A3 WO 2011093599A3 KR 2010009631 W KR2010009631 W KR 2010009631W WO 2011093599 A3 WO2011093599 A3 WO 2011093599A3
Authority
WO
WIPO (PCT)
Prior art keywords
yeast hydrolysate
food containing
containing same
menopausal symptoms
menopause
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2010/009631
Other languages
English (en)
Korean (ko)
Other versions
WO2011093599A2 (fr
Inventor
배송환
서형주
정은영
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SEROMBIO Co Ltd
Original Assignee
SEROMBIO Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SEROMBIO Co Ltd filed Critical SEROMBIO Co Ltd
Publication of WO2011093599A2 publication Critical patent/WO2011093599A2/fr
Publication of WO2011093599A3 publication Critical patent/WO2011093599A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • D—TEXTILES; PAPER
    • D05—SEWING; EMBROIDERING; TUFTING
    • D05B—SEWING
    • D05B35/00—Work-feeding or -handling elements not otherwise provided for
    • D05B35/06—Work-feeding or -handling elements not otherwise provided for for attaching bands, ribbons, strips, or tapes or for binding
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/14—Yeasts or derivatives thereof
    • A23L33/145—Extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • D—TEXTILES; PAPER
    • D05—SEWING; EMBROIDERING; TUFTING
    • D05B—SEWING
    • D05B29/00—Pressers; Presser feet
    • D05B29/06—Presser feet
    • D—TEXTILES; PAPER
    • D05—SEWING; EMBROIDERING; TUFTING
    • D05B—SEWING
    • D05B3/00—Sewing apparatus or machines with mechanism for lateral movement of the needle or the work or both for making ornamental pattern seams, for sewing buttonholes, for reinforcing openings, or for fastening articles, e.g. buttons, by sewing
    • D05B3/04—Sewing apparatus or machines with mechanism for lateral movement of the needle or the work or both for making ornamental pattern seams, for sewing buttonholes, for reinforcing openings, or for fastening articles, e.g. buttons, by sewing with mechanisms for work feed
    • D—TEXTILES; PAPER
    • D05—SEWING; EMBROIDERING; TUFTING
    • D05B—SEWING
    • D05B35/00—Work-feeding or -handling elements not otherwise provided for
    • D05B35/02—Work-feeding or -handling elements not otherwise provided for for facilitating seaming; Hem-turning elements; Hemmers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Textile Engineering (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne des compositions contenant un hydrolysat de levure destinées à prévenir et à améliorer les troubles climatériques ou liés à la ménopause et un procédé de préparation desdites compositions. Les compositions selon l'invention normalisent les hormones sanguines et améliorent le tissu osseux et autre et s'avèrent efficaces pour traiter divers symptômes et maladies provoqués par la ménopause tels que l'ostéoporose et la dépression et autres, la réduction des hormones sexuelles, et le dysfonctionnement ovarien.
PCT/KR2010/009631 2010-02-01 2010-12-31 Hydrolysat de levure pour soulager les symptômes de la ménopause chez la femme et aliment le contenant Ceased WO2011093599A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2010-0009304 2010-02-01
KR1020100009304A KR100989174B1 (ko) 2010-02-01 2010-02-01 여성 갱년기 증상개선에 효과를 갖는 효모 가수분해물 및 이를 포함하는 식품

Publications (2)

Publication Number Publication Date
WO2011093599A2 WO2011093599A2 (fr) 2011-08-04
WO2011093599A3 true WO2011093599A3 (fr) 2011-11-10

Family

ID=43135689

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/009631 Ceased WO2011093599A2 (fr) 2010-02-01 2010-12-31 Hydrolysat de levure pour soulager les symptômes de la ménopause chez la femme et aliment le contenant

Country Status (2)

Country Link
KR (1) KR100989174B1 (fr)
WO (1) WO2011093599A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101138714B1 (ko) * 2011-07-26 2012-04-24 (주)새롬바이오 효모 가수분해물을 유효성분으로 포함하는 연골세포 손상방지 및 재생효과를 갖는 조성물
KR101272606B1 (ko) 2013-03-15 2013-06-07 (주)에쎄르 식욕억제와 체중 감량, 지방 축적 억제의 효과를 갖는 효모 가수분해물과 이를 포함하는 식품 및 그 제조 방법
KR102163445B1 (ko) 2017-11-20 2020-10-07 주식회사 노브메타파마 Chp(사이클로-히스프로)를 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물
KR102115353B1 (ko) * 2019-05-17 2020-05-26 주식회사 노브메타파마 Chp(사이클로-히스프로) 및 부갑상선 호르몬을 포함하는 골 손실 질환의 예방, 개선 또는 치료용 조성물
CN112080540A (zh) * 2020-09-09 2020-12-15 广西普乐益生物科技有限公司 一种高核苷酸含量的酵母水解物及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040101934A1 (en) * 2001-02-27 2004-05-27 Choe Yun Seok Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and preparing process thereof
US20060140974A1 (en) * 2001-02-27 2006-06-29 Choe Yun S Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
WO2009064035A1 (fr) * 2007-11-12 2009-05-22 Serombio Co., Ltd Hydrolysat de levure stimulant la croissance et aliment diététique comprenant cet hydrolysat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100487887B1 (ko) 2001-05-14 2005-05-06 (주)뉴로타이드 월경 전기 증후군 및 월경통 완화의 기능을 갖는효모추출물, 이를 포함하는 조성물, 및 이들의 제조 방법

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040101934A1 (en) * 2001-02-27 2004-05-27 Choe Yun Seok Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and preparing process thereof
US20060140974A1 (en) * 2001-02-27 2006-06-29 Choe Yun S Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract
WO2009064035A1 (fr) * 2007-11-12 2009-05-22 Serombio Co., Ltd Hydrolysat de levure stimulant la croissance et aliment diététique comprenant cet hydrolysat

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C. WUSTER ET AL.: "Benefits of growth hormone treatment on bone metabolism, bone density and bone strength in growth hormonae deficiency and osteoporosis", GROWTH HORMONE AND IGF RESEARCH (SUPPL. A), vol. 8, 1998, pages 87 - 94, XP004866608, DOI: doi:10.1016/S1096-6374(98)80016-6 *
YOU KWANG-WON ET AL.: "The Reduction Effect of Yeast Hydrolysate SCP-20 on Premenstrual Syndrome", JOURNAL OF KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 30, no. 5, 2001, pages 1000 - 1003 *

Also Published As

Publication number Publication date
KR100989174B1 (ko) 2010-10-20
WO2011093599A2 (fr) 2011-08-04

Similar Documents

Publication Publication Date Title
WO2009126688A8 (fr) Compositions et procédés nouveaux pour le traitement de maladies de nature immunitaire
WO2013039365A3 (fr) Utilisation d'une composition édulcorante contenant un agent à digestion lente pour réduire le diabète
WO2013186240A3 (fr) Analogue peptidique d'exendine-4
WO2010115552A8 (fr) Anticorps anti-erbb-3/anti-c-met bispécifiques
IN2012DN00639A (fr)
WO2012076466A3 (fr) Acides carboxyliques 1-benzylcycloalkyle substitués et leur utilisation
WO2010049454A3 (fr) Composition antimicrobienne tirée de copépodes
MY164731A (en) Compound
WO2011090270A3 (fr) Composition contenant de l'osmotine pour prévenir et traiter des troubles neurologiques
PH12015501494A1 (en) Method for producing substituted 5-fluoro-1h-pyrazolopyrimidines
WO2009129260A3 (fr) Calycosine et ses analogues utilises dans le traitement des maladies induites par les recepteurs beta des oestrogenes
WO2010053600A3 (fr) Nyasol et ses analogues pour le traitement de maladies à médiation par le récepteur bêta des oestrogènes
WO2010137846A3 (fr) Composition pour accroître de la biodisponibilité de la saponine
WO2011093599A3 (fr) Hydrolysat de levure pour soulager les symptômes de la ménopause chez la femme et aliment le contenant
WO2012037562A3 (fr) Compositions pharmaceutiques et nutraceutiques d'acide abscisique
WO2013058484A3 (fr) Composé diterpène de type ingénane et composition pharmaceutique pour le traitement ou la prévention de maladies infectieuses virales le contenant
WO2010011581A3 (fr) Extrait polysaccharidique de dendrobium pour traiter des maladies allergiques
WO2011061744A3 (fr) Nouveaux camphènes arylés, procédés de préparation et utilisations de ceux-ci
WO2012075015A3 (fr) Compositions pharmaceutiques orales de métronidazole
WO2011025978A3 (fr) Méthodes de traitement faisant appel à des anticorps anti-ldl oxydées
WO2010117346A3 (fr) Compositions pharmaceutiques stables à forte biodisponibilité
WO2010094837A3 (fr) Produit sucré
WO2013025073A3 (fr) Composition pour la prévention ou le traitement de complications du diabète contenant un extrait de quamoclit pennata
WO2013100718A3 (fr) Composition pharmaceutique permettant de prévenir ou de traiter des maladies inflammatoires ou l'asthme, contenant un extrait de lagerstroemia ovalifolia ou une fraction de celle-ci en tant que principe actif
WO2013007447A3 (fr) Composition comestible

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10844823

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10844823

Country of ref document: EP

Kind code of ref document: A2